<p>Dr. Hiddo J.L. Heerspink discusses the findings from his study, "Effect of Avenciguat on Albuminuria in Patients with CKD: Two Randomized Placebo-Controlled Trials" with JASN Editor-in-Chief Rajnish Mehrotra.</p>

Dr. Hiddo J.L. Heerspink discusses the findings from his study, "Effect of Avenciguat on Albuminuria in Patients with CKD: Two Randomized Placebo-Controlled Trials" with JASN Editor-in-Chief Rajnish Mehrotra.

sGC Activator Avenciguat for CKD

JASN publishes original research reports and basic and clinical science papers relevant to the broad discipline of nephrology. The JASN Podcast features discussions with authors of recently published articles. Moderated by JASN EIC, Josie Briggs, and the editorial fellows, each episode gives a behind the scenes look into the conception of the latest journal articles. New episodes monthly.

Also featured are special issue highlights episodes, which showcase 4-6 articles hand-picked by the EIC for their interest and impact.

JASN publishes original research reports and basic and clinical science papers relevant to the broad discipline of nephrology. The JASN Podcast features discussions with authors of recently published articles. Moderated by JASN EIC, Josie Briggs, and the editorial fellows, each episode gives a behind the scenes look into the conception of the latest journal articles. New episodes monthly. Also featured are special issue highlights episodes, which showcase 4-6 articles hand-picked by the EIC for their interest and impact.

Share sGC Activator Avenciguat for CKD

Sign up to save your podcasts

sGC Activator Avenciguat for CKD

sGC Activator Avenciguat for CKD